Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...

Novo Nordisk moved to cut U.S. prices on its leading GLP-1 weight-loss and diabetes drugs as competitive pressure from Eli ...

Oral weight-loss pills will be replacing GLP-1 shots by March 2026, Medicare and Medicaid Services Administrator Dr. Mehmet Oz predicted on Monday. Oz made the statement during a Monday morning ...

Trump touted a new TrumpRx deal promising obesity drugs like Wegovy and Zepbound for about $250 monthly, but experts warn the plan is unclear, includes unapproved products, and only discounts low ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

WASHINGTON, DC — The Trump administration is negotiating with the makers of weight-loss drugs to lower their prices. According to the Wall Street Journal, the deal would allow the lowest doses of ...

Oct 29 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Wednesday it is partnering with Walmart (WMT.N), opens new tab to sell its weight-loss treatment Zepbound at the retailer's pharmacies ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year. “We’ve already made, actually, ...

More than 12% of students use non-prescription weight-loss supplements, almost half of them without prior medical consultation, a new study of undergraduates at an Egyptian university finds. The ...

GLP-1 medications are continuing to grow in popularity, but not everyone is eligible for them. As a result, some are opting to take weight-loss supplements instead, which doctors warn can be unsafe.